Differential effects of NOD2 polymorphisms on colorectal cancer risk: a meta-analysis
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Since Kurzawski et al. described an association between the 3020insC NOD2 single nucleotide polymorphism and the risk of colorectal cancer(CRC) in 2004, reports published in the past several years have controversial results regarding the relationship between the development of CRC and NOD2 gene polymorphisms. To clarify the potential role of NOD2 P286S, R702W, G908R, and 3020insC polymorphisms in CRC patients, we have undertaken a systematic review and meta-analysis of published articles.
Materials and methods
Studies reporting on NOD2 polymorphisms and CRC were searched in the PubMed, EMBASE, and the Science Citation Index from the inception of each database to May, 2009. The search strategy included the keywords “CRC”, “colon cancer”, “rectal cancer”, “polymorphism”, and “NOD2/CARD15”.
Eight eligible case-control studies about Caucasians from four countries contributed data on 5,888 subjects (cases: 3,524; controls: 2,364). Compared to the wild genotype, the R702W, G908R, and 3020insC polymorphisms were associated with an increased risk of CRC (odds ratio (OR): 1.59, 1.98, 1.44; 95% confidence interval (CI): 1.09–2.32, 1.14–3.44, 1.13–1.84; P = 0.02, 0.01, 0.003). However, P268S polymorphism did not influence CRC risk (OR: 1.27; CI: 0.32–5.00; P = 0.73).
These findings indicate that NOD2 R702W, G908R, and 3020insC polymorphisms contribute to CRC susceptibility in Caucasians. Meta-analysis of these polymorphisms in NOD2 gene will help determine their role in CRC carcinogenesis.
- Differential effects of NOD2 polymorphisms on colorectal cancer risk: a meta-analysis
International Journal of Colorectal Disease
Volume 25, Issue 2 , pp 161-168
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Colorectal cancer
- Industry Sectors
- Author Affiliations
- 1. Tumor Institute, China Medical University, Shenyang, Liaoning, China
- 2. Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
- 3. Department of Pathology, Jilin University, Changchun, Jilin, China